Antonio Santoro

Title: Antonio Santoro: Innovator in Myeloma Treatment

Introduction

Antonio Santoro is a notable inventor based in San Lazzaro di Savena, Italy. He has made significant contributions to the field of medical technology, particularly in the treatment of myeloma patients. His innovative approach has led to the development of a unique patent that addresses critical challenges in patient care.

Latest Patents

Antonio Santoro holds a patent for a "Kit, system and method of treating myeloma patients." This invention focuses on the role of circulating free lambda and kappa free light chains in the pathogenesis of acute renal failure due to myeloma. The patented method utilizes coupled plasma filtration and adsorption to separate plasma from blood. It involves treatment through a cartridge containing a sorbent or resin material, specifically hydrophobic divinylbenzene styrenic resins. These resins have an average bead diameter of 75 microns, an average pore diameter of 30 nm, and a surface area of 700 m²/g. The treatment results in a progressive decrease in lambda and kappa free light chain concentrations, leading to significant reductions by the end of the process.

Career Highlights

Antonio Santoro is associated with Bellco S.r.l., a company that specializes in medical devices and technologies. His work at Bellco has allowed him to focus on innovative solutions for patient treatment, particularly in the area of myeloma. His dedication to improving patient outcomes is evident in his research and development efforts.

Collaborations

Antonio has collaborated with notable colleagues, including Mauro Atti and Mary Lou Wratten. These partnerships have contributed to the advancement of his research and the successful implementation of his patented technologies.

Conclusion

Antonio Santoro's contributions to the field of myeloma treatment through his innovative patent demonstrate his commitment to enhancing patient care. His work continues to impact the medical community positively, paving the way for future advancements in treatment methodologies.